168 related articles for article (PubMed ID: 33302222)
1. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
2. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract][Full Text] [Related]
3. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
[TBL] [Abstract][Full Text] [Related]
4. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
6. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
Chen W; Hornick JL; Fletcher CDM
Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
[TBL] [Abstract][Full Text] [Related]
7. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
10. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
[TBL] [Abstract][Full Text] [Related]
11. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
[TBL] [Abstract][Full Text] [Related]
12. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
[TBL] [Abstract][Full Text] [Related]
13. Ewing sarcoma and Ewing-like tumors.
Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP
Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230
[TBL] [Abstract][Full Text] [Related]
14. CD99 reactivity in mesenchymal chondrosarcoma.
Granter SR; Renshaw AA; Fletcher CD; Bhan AK; Rosenberg AE
Hum Pathol; 1996 Dec; 27(12):1273-6. PubMed ID: 8958297
[TBL] [Abstract][Full Text] [Related]
15. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
16. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
[TBL] [Abstract][Full Text] [Related]
18. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents.
Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R
Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
